Results 161 to 170 of about 34,705 (216)

ARC-18 Improved Motor Performance Through Inhibiting ACLY-Mediated Smad2/3 Acetylation in a Model of Duchenne Muscular Dystrophy. [PDF]

J Cachexia Sarcopenia Muscle
Chen C, Zhang B, Yang C, Wang J, He Y, Yu H, Liu J, Xie Y, Yang X, Liu GP.   +9 more
europepmc   +1 more source

Characterization of a humanized mouse model of Duchenne muscular dystrophy to support the development of genetic medicines.

Dis Model Mech
Braunreiter K, Kempton A, Mejia-Guerra MK, Murray A, Baine S, Adegboye K, Haile A, Kumar Ahuja SJ, Fedoce A, Liu C, Burch P, Kabadi AM.   +11 more
europepmc   +1 more source

Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle. [PDF]

JCI Insight
Johnson EE, Reyes TR, Chamberlain JS, Ervasti JM, Tasfaout H.   +4 more
europepmc   +1 more source

Synthetic bottlebrush block copolymer prevents disease onset in Duchenne muscular dystrophy. [PDF]

Proc Natl Acad Sci U S A
Cohen H, Angulski ABB, Quick JD, Kuebler TS, Thompson BR, Bauer J, Hahn D, Townsend D, Hassler JF, Hackel BJ, Lodge TP, Sham YY, Bates FS, Metzger JM.   +13 more
europepmc   +1 more source

Lymphatic dysfunction is linked to disease pathogenesis in Duchenne muscular dystrophy animal models. [PDF]

Proc Natl Acad Sci U S A
Subramanian B, Johnson S, Narayanan A, Wang W, Seaberg BL, Ball J, Paredes Mares IM, Majumder A, Aceves A, Frazier SE, Rutledge A, Griffin JF, Pal S, Zawieja S, Davis MJ, Rutkowski JM, Nghiem PP, Rimer M, Muthuchamy M.   +18 more
europepmc   +1 more source

A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models. [PDF]

Sci Rep
Mantuano P, van Putten M, Cobb BS, Putker K, Boccanegra B, Tanganyika-de Winter C, Tulimiero L, Schneider AF, Cappellari O, Van De Vijver D, Engelbeen S, Pandeya S, Nagy JA, Rutkove S.   +13 more
europepmc   +1 more source

Targeting cellular senescence in dystrophin^-/-/utrophin^-/-double knockout mice improves musculoskeletal health and increases lifespan. [PDF]

Pharmacol Res
Gao X, Ruzbarsky JJ, Huard M, Sajedi SAH, Shyu PT, Xiao Z, Force BS, White S, Ayers J, Wang B, Guo XE, Huard J.   +11 more
europepmc   +1 more source

Central Neurophysiological Alterations in Dystrophic mdx Mice Correlate With Reduced Hippocampal Levels of the Endogenous NMDA Receptor Ligand D-Aspartate. [PDF]

J Neurochem
Mastrostefano F, Garofalo M, Nuzzo T, Bruno C, Errico F, Usiello A, De Stefano ME.   +6 more
europepmc   +1 more source

Histone deacetylases in Duchenne muscular dystrophy: a role in the mechanism of disease and a target for inhibition. [PDF]

Clin Epigenetics
Bertoldi M, Albamonte E, Bello L, D'amico A, Masson R, Nigro V, Pane M, Panicucci C, Sframeli M, Ricci F.   +9 more
europepmc   +1 more source

Short-term daily deflazacort decreases membrane permeability and increases maximum force in <i>mdx</i> mice. [PDF]

Am J Physiol Cell Physiol
Turner KD, Qian Y, Claflin DR, Newell-Stamper BL, Peter AK, Michele DE, Russell AJ, Brooks SV.   +7 more
europepmc   +1 more source